Jackson, David J.; Korn, Stephanie; Mathur, Sameer K. et al.
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on BenralizumabDRUG SAFETY. Bd. 43. H. 5. 2020 S. 409-425
Steetskamp, Joscha; Bachmann, Elisabeth; Hasenburg, Annette et al.
Safety of misoprostol for near-term and term induction in small-for-gestational-age pregnancies compared to dinoprostone and primary cesarean section: results of a retrospective cohort studyARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 302. H. 6. 2020 S. 1369-1374
Ciplea, Andrea Ines; Langer-Gould, Annette; Stahl, Anna et al.
Safety of potential breast milk exposure to IFN-beta or glatiramer acetate One-year infant outcomesNEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. Bd. 7. H. 4. 2020
Ostuzzi, Giovanni; Papola, Davide; Gastaldon, Chiara et al.
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendationsBMC MEDICINE. Bd. 18. H. 1. 2020
Ostuzzi, Giovanni; Papola, Davide; Gastaldon, Chiara et al.
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations (vol 18, 215, 2020)BMC MEDICINE. Bd. 18. H. 1. 2020
Lotti, Torello; Agarwal, Komal; Podder, Indrashis et al.
Safety of the current drug treatments for vitiligoEXPERT OPINION ON DRUG SAFETY. Bd. 19. H. 4. 2020 S. 499-511
Goebel, Sebastian; Schwuchow-Thonke, Soeren; Jansen, Thomas et al.
Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsyESC HEART FAILURE. 2020
Kis, Bernhard; Luecke, Caroline; Abdel-Hamid, Mona et al.
Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients - Results of the COMPAS StudyPHARMACOPSYCHIATRY. 2020
Koss, Michael Janusz; Bolz, Matthias; Augustin, Albert J. et al.
Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal InjectionsKLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE. Bd. 237. H. 1. 2020 S. 90-94
Hoelig, Kristina; Schmidt, Helmuth; Huetter, Gero et al.
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialBONE MARROW TRANSPLANTATION. 2020